InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Q32 Bio Inc.

FIXX Clue Score74
United States Fiscal year ends December CIK 0001661998
$13.81 +1.02% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $13.81 +9.21% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 19 Aug 2026. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Operating income−29.7Net income−30.0Fiscal year 2018Revenue5.3Operating income−59.9Net income−55.6Fiscal year 2019Revenue1.7 −68.7%Operating income−109.9Net income−103.9Fiscal year 2020Revenue2.7 +62.2%Operating income−130.3Net income−128.7Fiscal year 2021Revenue34.0 +1,157.3%Operating income−95.9Net income−95.8EPS, diluted−1.73Fiscal year 2022Revenue3.2 −90.6%Operating income−133.3Net income−5.0EPS, diluted−0.09Fiscal year 2023Revenue1.2 −64.0%Operating income−48.3Net income−53.7EPS, diluted−153.96Fiscal year 2024Revenue0.0 −100.0%Operating income−66.1Net income−47.7EPS, diluted−6.58Fiscal year 2025Revenue53.7Operating income16.9Net income29.8EPS, diluted2.42
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a 5.3 1.7 2.7 34.0 3.2 1.2 0.0 53.7
Growth −68.7% +62.2% +1,157.3% −90.6% −64.0% −100.0%
Operating income −29.7 −59.9 −109.9 −130.3 −95.9 −133.3 −48.3 −66.1 16.9
Net income −30.0 −55.6 −103.9 −128.7 −95.8 −5.0 −53.7 −47.7 29.8
Growth
EPS, diluted n/a n/a n/a n/a −1.73 −0.09 −153.96 −6.58 2.42

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2017Fiscal year 2018Operating margin−1,126.0%Net margin−1,044.3%Free cash flow margin−1,268.3%Fiscal year 2019Operating margin−6,599.2%Net margin−6,237.5%Free cash flow margin−6,794.2%Fiscal year 2020Operating margin−4,821.0%Net margin−4,762.9%Free cash flow margin−3,629.3%Fiscal year 2021Operating margin−282.4%Net margin−281.9%Free cash flow margin−330.1%Fiscal year 2022Operating margin−4,154.6%Net margin−156.0%Free cash flow margin−3,583.1%Fiscal year 2023Operating margin−4,174.3%Net margin−4,649.0%Free cash flow margin−1,616.1%Fiscal year 2024Fiscal year 2025Operating margin31.5%Net margin55.5%Free cash flow margin−62.4%
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin n/a −1,126.0% −6,599.2% −4,821.0% −282.4% −4,154.6% −4,174.3% n/a 31.5%
Net margin n/a −1,044.3% −6,237.5% −4,762.9% −281.9% −156.0% −4,649.0% n/a 55.5%
Free cash flow margin n/a −1,268.3% −6,794.2% −3,629.3% −330.1% −3,583.1% −1,616.1% n/a −62.4%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow6.5Capital expenditure−2.0Free cash flow4.5Fiscal year 2018Operating cash flow−42.6Capital expenditure−24.9Free cash flow−67.5 −1,593.1%Fiscal year 2019Operating cash flow−91.4Capital expenditure−21.8Free cash flow−113.2Fiscal year 2020Operating cash flow−94.3Capital expenditure−3.7Free cash flow−98.1Fiscal year 2021Operating cash flow−109.8Capital expenditure−2.4Free cash flow−112.1Fiscal year 2022Operating cash flow−113.7Capital expenditure−1.3Free cash flow−114.9Fiscal year 2023Operating cash flow−18.7Capital expenditure−0.0Free cash flow−18.7Fiscal year 2024Operating cash flow−67.7Capital expenditure−0.1Free cash flow−67.8Fiscal year 2025Operating cash flow−33.5Capital expenditure0.0Free cash flow−33.5
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 6.5 −42.6 −91.4 −94.3 −109.8 −113.7 −18.7 −67.7 −33.5
Capital expenditure −2.0 −24.9 −21.8 −3.7 −2.4 −1.3 −0.0 −0.1 0.0
Free cash flow 4.5 −67.5 −113.2 −98.1 −112.1 −114.9 −18.7 −67.8 −33.5
Growth −1,593.1%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2017Cash51.6Shareholders’ equity−39.5Fiscal year 2018Cash38.2Shareholders’ equity196.4Fiscal year 2019Cash53.8Shareholders’ equity258.5Fiscal year 2020Cash217.4Shareholders’ equity196.0Fiscal year 2021Cash108.4Shareholders’ equity169.7Fiscal year 2022Cash34.0Shareholders’ equity−130.7Fiscal year 2023Cash25.6Shareholders’ equity−182.9Fiscal year 2024Cash78.0Shareholders’ equity5.7Fiscal year 2025Cash48.3Shareholders’ equity42.0
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 51.6 38.2 53.8 217.4 108.4 34.0 25.6 78.0 48.3
Shareholders’ equity −39.5 196.4 258.5 196.0 169.7 −130.7 −182.9 5.7 42.0

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Margins
n/a −1,126.0% −6,599.2% −4,821.0% −282.4% −4,154.6% −4,174.3% n/a 31.5%
n/a n/a n/a n/a −281.9% 37.3% −7,532.9% n/a 55.5%
n/a −1,044.3% −6,237.5% −4,762.9% −281.9% −156.0% −4,649.0% n/a 55.5%
n/a −1,268.3% −6,794.2% −3,629.3% −330.1% −3,583.1% −1,616.1% n/a −62.4%
Spending
n/a 900.9% 5,366.0% 3,715.5% 274.0% 3,065.8% 2,744.7% n/a 35.6%
n/a 325.1% 1,333.2% 1,205.5% 108.4% 1,188.8% 854.2% n/a 32.9%
n/a 468.6% 1,310.5% 138.2% 7.1% 40.1% 0.4% n/a 0.0%
n/a n/a n/a n/a n/a 59.7% n/a n/a 0.0%
Returns
n/a −28.3% −40.2% −65.7% −56.4% n/a n/a −841.1% 71.0%
−21.8% −21.5% −33.5% −48.8% −45.2% −2.2% −114.2% −51.7% 48.3%
Balance and payout
28.5% 24.2% 16.8% 25.7% 19.9% 22.1% 251.9% 93.9% 32.0%